New patent for BDSI drug SYMPROIC

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SYMPROIC
Annual Drug Patent Expirations for SYMPROIC

Symproic is a drug marketed by Bdsi and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

SYMPROIC drug price trends.

This drug has fifty-five patent family members in twenty-five countries.

The generic ingredient in SYMPROIC is naldemedine tosylate. One supplier is listed for this compound. Additional details are available on the naldemedine tosylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top